Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- 1 Mapping the Terrain of Bipolar II Disorder
- 2 Bipolar Disorder in Historical Perspective
- 3 The Bipolar Spectrum
- 4 Defining and Measuring Bipolar II Disorder as a Categorical Condition
- 5 Bipolar II Disorder in Context: A Review of Its Epidemiology, Disability and Economic Burden
- 6 Comorbid Conditions Associated with Bipolar II Disorder
- 7 Personality and Temperament Styles Associated with Bipolar II Disorder
- 8 Differentiating Bipolar II Disorder from Personality-based Dysregulation Disorders
- 9 The Neurobiology of Bipolar II Disorder
- 10 Methodological Nuances in Undertaking and Interpreting Efficacy Studies of Medications for Bipolar II Disorder
- 11 The Role of Antidepressants in Managing Bipolar II Disorder
- 12 Mood Stabilisers in the Treatment of Bipolar II Disorder
- 13 The Use of Antipsychotic Drugs in Bipolar II Disorder
- 14 Perinatal Nuances in Managing Bipolar II Disorder
- 15 Psychological Interventions for Bipolar II Disorder
- 16 The Role of Well-Being Plans in Managing Bipolar II Disorder
- 17 The Trajectory of Illness Experienced by Those with a Bipolar II Disorder
- Section 2 Management Commentaries
- Section 3 Conclusion
- Index
- References
14 - Perinatal Nuances in Managing Bipolar II Disorder
from Section 1 - Domain Chapters
Published online by Cambridge University Press: 17 December 2018
Edited by
Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- 1 Mapping the Terrain of Bipolar II Disorder
- 2 Bipolar Disorder in Historical Perspective
- 3 The Bipolar Spectrum
- 4 Defining and Measuring Bipolar II Disorder as a Categorical Condition
- 5 Bipolar II Disorder in Context: A Review of Its Epidemiology, Disability and Economic Burden
- 6 Comorbid Conditions Associated with Bipolar II Disorder
- 7 Personality and Temperament Styles Associated with Bipolar II Disorder
- 8 Differentiating Bipolar II Disorder from Personality-based Dysregulation Disorders
- 9 The Neurobiology of Bipolar II Disorder
- 10 Methodological Nuances in Undertaking and Interpreting Efficacy Studies of Medications for Bipolar II Disorder
- 11 The Role of Antidepressants in Managing Bipolar II Disorder
- 12 Mood Stabilisers in the Treatment of Bipolar II Disorder
- 13 The Use of Antipsychotic Drugs in Bipolar II Disorder
- 14 Perinatal Nuances in Managing Bipolar II Disorder
- 15 Psychological Interventions for Bipolar II Disorder
- 16 The Role of Well-Being Plans in Managing Bipolar II Disorder
- 17 The Trajectory of Illness Experienced by Those with a Bipolar II Disorder
- Section 2 Management Commentaries
- Section 3 Conclusion
- Index
- References
- Type
- Chapter
- Information
- Bipolar II DisorderModelling, Measuring and Managing, pp. 151 - 162Publisher: Cambridge University PressPrint publication year: 2019
References
American Psychiatric Association. (2002). Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry, 168, 1–50.Google Scholar
American Psychiatric Association (2005). Guideline Watch for the Practice Guideline for the Treatment of Patients with Bipolar Disorder. Arlington, VA: American Psychiatric Association Publishing.Google Scholar
Bassett, D., Mulder, R., Outhred, T., et al. (2017). Defining disorders with permeable borders: you say bipolar, I say borderline! Bipolar disorders, 19, 320–3.Google Scholar
Bayes, A., Parker, G. and Fletcher, K. (2014) Clinical differentiation of bipolar II disorder from borderline personality disorder. Current Opinion in Psychiatry, 27, 14–20.Google Scholar
Bérard, A., Sheehy, O., Zhao, J. P., et al. (2017). SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. British Journal of Clinical Pharmacology, 83, 1126–33.Google Scholar
Boyce, P. and Buist, A. (2016). Management of bipolar disorder over the perinatal period. Australian Family Physician, 45, 890–3.Google Scholar
Christensen, J., Grønborg, T. K., Sørensen, M. J., et al. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 309, 1696–703.Google Scholar
Clark, C. T., Klein, A. M., Perel, J. M., et al. (2013). Lamotrigine dosing for pregnant patients with bipolar disorder. American Journal of Psychiatry, 170, 1240–7.Google Scholar
Diav‐Citrin, O., Shechtman, S., Zvi, N., et al. (2017). Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study. Birth Defects Research, 109, 1196–03CrossRefGoogle ScholarPubMed
Doyle, K., Heron, J., Berrisford, G., et al. (2012). The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse. European Psychiatry, 27, 563–9.CrossRefGoogle ScholarPubMed
Eyden, J., Winsper, C., Wolke, D., et al. (2016) A systematic review of the parenting and outcomes experienced by offspring of mothers with borderline personality pathology: potential mechanisms and clinical implications. Clinical Psychology Review, 47, 85–105.Google Scholar
Fountoulakis, K. N., Grunze, H., Vieta, E., et al. (2016). The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. International Journal of Neuropsychopharmacology, 20, 180–95.Google Scholar
Galbally, M., Snellen, M., Walker, S., et al. (2010). Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Australian & New Zealand Journal of Psychiatry, 44, 99–108.Google Scholar
Goodwin, G. M. and Consensus Group of the British Association for Psychopharmacology (2009). Evidence-based guidelines for treating bipolar disorder, revised second edition: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 23, 346–88.CrossRefGoogle ScholarPubMed
Goodwin, G. M., Haddad, P. M., Ferrier, I. N., et al. (2016). Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30, 495–553.Google Scholar
Graham, R., Tavella, G. and Parker, G. (2018). Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? Journal of Affective Disorders, 228, 216–21.Google Scholar
Grunze, H., Vieta, E., Goodwin, G. M., et al. (2009). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World Journal of Biological Psychiatry, 10, 85–116.CrossRefGoogle ScholarPubMed
Grunze, H., Vieta, E., Goodwin, G. M., et al. (2010). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World Journal of Biological Psychiatry, 11, 81–109.CrossRefGoogle ScholarPubMed
Grunze, H., Vieta, E., Goodwin, G. M., et al. (2013). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar depression. World Journal of Biological Psychiatry, 14, 154–219.CrossRefGoogle Scholar
Hunt, N. and Silverstone, T. (1995). Does puerperal illness distinguish a subgroup of bipolar patients? Journal of Affective Disorders, 34, 101–7.Google Scholar
Huybrechts, K. F., Hernández-Díaz, S., Patorno, E., et al. (2016). Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry, 73, 938–46.CrossRefGoogle ScholarPubMed
Kanba, S., Kato, T., Terao, T., et al. (2013). Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders. Psychiatry and Clinical Neurosciences, 67, 285–300.Google Scholar
Khan, S. J., Fersh, M. E., Ernst, C., et al. (2016). Bipolar disorder in pregnancy and postpartum: principles of management. Current Psychiatry Reports, 18, 13.CrossRefGoogle ScholarPubMed
Malhi, G. S., Bassett, D., Boyce, P., et al. (2015). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry, 49, 1087–206.CrossRefGoogle ScholarPubMed
Management of Bipolar Disorder Working Group (2010). VA/DoD Clinical Practice Guideline for Management of Bipolar Disorder in Adults. Washington, DC: Department of Veterans Affairs, Department of Defense.Google Scholar
Morriss, R. (2004) The early warning symptom intervention for patients with bipolar affective disorder. Advances in Psychiatric Treatment, 10, 18–26.Google Scholar
Muzik, M. and Hamilton, S. E. (2016). Use of antidepressants during pregnancy?: What to consider when weighing treatment with antidepressants against untreated depression. Maternal and Child Health Journal, 20, 2268–79.Google Scholar
National Institute for Health and Care Excellence. (2014). Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance. London: National Institute for Health and Care Excellence.Google Scholar
Ornoy, A., Weinstein‐Fudim, L. and Ergaz, Z. (2017). Antidepressants, antipsychotics, and mood stabilizers in pregnancy: what do we know and how should we treat pregnant women with depression. Birth Defects Research, 109, 933–56.CrossRefGoogle ScholarPubMed
Ostacher, M. J., Tandon, R. and Suppes, T. (2016). Florida Best Practice psychotherapeutic medication guidelines for adults with bipolar disorder: a novel, practical, patient-centered guide for clinicians. Journal of Clinical Psychiatry, 77, 920–6.Google Scholar
Ozturk, Z., Olmez, E., Gurpinar, T., et al. (2016). Safety of psychotropic medications in pregnancy: an observational cohort study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 26, 229–37.Google Scholar
Parker, G., Eyers, K. and Boyce, P. (2014). Overcoming Baby Blues. Sydney: Allen and Unwin.Google Scholar
Patorno, E., Huybrechts, K. F., Bateman, B. T., et al. (2017). Lithium use in pregnancy and the risk of cardiac malformations. New England Journal of Medicine, 376, 2245–54.Google Scholar
Perry, A., Tarrier, N., Morriss, R., et al. (1999) Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ, 318, 149–53.Google Scholar
Shah, N., Grover, S. and Rao, G. P. (2017). Clinical practice guidelines for management of bipolar disorder. Indian Journal of Psychiatry, 59, S51–66.Google Scholar
Sharma, V. and Mazmanian, D. (2003) Sleep loss and postpartum psychosis. Bipolar Disorders, 5, 98–105.CrossRefGoogle ScholarPubMed
Snellen, M. and Malhi, G. S. (2014) Bipolar disorder, psychopharmacology, and pregnancy. In: Galbally, M., Snellen, M. and Lewis, A. (eds) Psychopharmacology and Pregnancy: Treatment Efficacy, Risks, and Guidelines. New York, NY: Springer-Verlag Publishing, 103–17.Google Scholar
Snellen, M., Thompson, G. and Murdoch, N. (2014) The process of obtaining informed consent when prescribing psychopharmacology in pregnancy. In: Galbally, M, Snellen, M and Lewis, A (eds) Psychopharmacology and Pregnancy – Treatment Efficacy, Risks, and Guidelines. Treatment Efficacy, Risks, and Guidelines. Berlin Heidelberg: Springer-Verlag, 5–18.Google Scholar
Soussan, C., Gouraud, A., Portolan, G., et al. (2014). Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database. European Journal of Clinical Pharmacology, 70, 1361–6.Google Scholar
Viguera, A. C., Nonacs, R., Cohen, L. S., et al. (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. American Journal of Psychiatry, 157, 179–84.Google Scholar
Viguera, A. C., Tondo, L., Koukopoulos, A. E., et al. (2011). Episodes of mood disorders in 2,252 pregnancies and postpartum periods. American Journal of Psychiatry, 168, 1179–85.Google Scholar
Viguera, A. C., Whitfield, T., Baldessarini, R. J., et al. (2007). Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. American Journal of Psychiatry, 164, 1817–24.CrossRefGoogle ScholarPubMed
Vitale, S. G., Laganà, A. S., Muscatello, M. R. A., et al. (2016). Psychopharmacotherapy in pregnancy and breastfeeding. Obstetrical & Gynecological Survey, 71, 721–33.CrossRefGoogle ScholarPubMed
Wesseloo, R., Kamperman, A. M., Munk-Olsen, T., et al. (2015). Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. American Journal of Psychiatry, 173, 117–27.Google Scholar
World Health Organization. (2009). Pharmacological Treatment of Mental Disorders in Primary Health Care. Geneva, Switzerland: World Health OrganizationGoogle Scholar
Yatham, L. N., Kennedy, S. H., Parikh, S. V., et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders, 15, 1–44.CrossRefGoogle Scholar
Yonkers, K. A., Wisner, K. L., Stowe, Z., et al. (2004). Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry, 161, 608–20.Google Scholar